Mim8 Bispecific Antibody Prophylaxis in Hemophilia A with or without Inhibitors

Maria Elisa Mancuso

Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan

Anthony K.C. Chan

McMaster Children’s Hospital, McMaster University, Hamilton, ON, Canada

Chandrakala Shanmukhaiah

Department of Clinical Hematology, Seth G.S. Medical College and King Edward Memorial Hospital, Mumbai, India

Chuhl Joo Lyu

Department of Pediatrics, Yonsei University Severance Hospital, Seoul, South Korea

Joanna Zdziarska

Department of Hematology, Jagiellonian University Medical College, Kraków, Poland

Johnny Mahlangu

Department of Molecular Medicine and Haematology, Faculty of Health Sciences, University of the Witwatersrand and National Health Laboratory Service, Johannesburg

Lize F.D. van Vulpen

Center for Benign Hematology, Thrombosis, and Hemostasis, Van Creveldkliniek, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands

Pratima Chowdary

Katharine Dormandy Haemophilia and Thrombosis Centre, Royal Free Hospital, Department of Haematology, Cancer Institute, University College London, London

Renchi Yang

State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China

Steven R. Lentz

Department of Internal Medicine, University of Iowa, Iowa City

Tadashi Matsushita

Department of Transfusion Medicine, Nagoya University Hospital, Nagoya, Japan

Wan Hui Ong Clausen

Novo Nordisk, Søborg, Denmark

Ilgiz Rakhmatullin

Novo Nordisk, Søborg, Denmark

Johannes Oldenburg